Clinical Trials Overview

We are devoted to discovering and developing medicines that reduce suffering and improve the lives of patients with the most difficult-to-treat cancers. As part of that process, we must conduct clinical trials to establish their efficacy, safety and tolerability to gain approval from regulatory agencies in the United States and around the world.

Patient participation in clinical trials is important. If you are chosen to enroll in one of our trials, you will be participating in important health research and helping to advance the scientific understanding of cancer.

Read more to see where our clinical trial sites are located and the types of cancer for which we are evaluating our investigational medicines.

Find Clinical Trials Near Me

Study Phase Cancer Type(s) Investigational Medicine Status  
Phase 1b Renal cell carcinoma (RCC) CPI-444 + atezolizumab Enrolling More Info
Phase 1b/2 (MORPHEUS)* Non-small cell lung cancer (NSCLC) CPI-444 + atezolizumab Enrolling More Info
Phase 1/1b NSCLC, RCC, other solid tumors CPI-006
CPI-006 + CPI-444
CPI-006 + pembrolizumab
Enrolling More Info

*Conducted by Genentech.

For more information on our product candidates, please see our Annual Report available in the SEC Filings section of the website.

Our Science

We are developing oncology medicines with differentiated mechanisms of action directed at precisely-defined molecular targets

Who We Are

We are committed to developing better medicines to improve the lives of people with the most difficult-to-treat cancers